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Abstract
Mixtures of cationic lipids and unsaturated phosphatidylethanolamine are used extensively for the intracellular delivery of
plasmids and antisense oligodeoxynucleotides (ODN) in vitro. However, the mechanism by which cytoplasmic delivery of
these large molecules is achieved remains unclear. The common hypothesis is that phosphatidylethanolamine promotes
fusion of lipid/DNA particles with endosomal membranes, but this is inconsistent with several reports that have failed to
correlate the fusogenic activity of a wide variety of lipid/DNA particles, measured by lipid mixing techniques, with their
transfection activity. To address this issue further we have conducted a detailed analysis of the lipid mixing and DNA
transfer activity of two, physically similar but functionally different, lipid/DNA particles composed of equimolar
dioleyldimethylammonium chloride (DODAC) and dioleoylphosphatidylethanolamine (DOPE) or dioleoylphosphatidylcho-
line (DOPC). In combination with DODAC both phospholipids form almost identical lipid/DNA particles, they are
endocytosed by cells to the same extent and each undergoes equivalent lipid mixing with cell membranes after uptake.
Despite this, DNA transfer is 10- to 100-fold more extensive for lipid/DNA particles containing DOPE. We conclude that
lipid mixing between lipid-based delivery systems and endosomal membranes must occur for DNA transfer to occur.
However, the potency of different lipid/DNA particles correlates better with the ability of the exogenous lipid to disrupt
membrane integrity. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
The mechanism of lipid-mediated transfection (lip-
ofection) has attracted a great deal of attention in
recent years because of the need to develop non-viral,
intracellular delivery systems for genes and antisense
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Abbreviations: BSA, bovine serum albumin; CHE, cholesterol hexadecylether; DMEM, Dulbecco’s modi¢ed Eagle’s medium; DO-
DAC, dioleyldimethylammonium chloride; DOPC, dioleoylphosphatidylcholine; DOPE, dioleoyphosphatidylethanolamine; EDTA,
ethylenediaminetetraacetic acid; EGFR, epidermal growth factor receptor; FBS, fetal bovine serum; FITC, £uorescein isothiocyanate;
G3PDH, glyceraldehyde 3-phosphate dehydrogenase; HBS, HEPES bu¡ered saline; HBSS, Hanks bu¡er saline; HEPES, 4-(hydroxy-
ethyl)-1-piperazineethanesulfonic acid; MES, 2-(N-morpholino)-ethanesulfonic acid; NBD-PE, N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)dio-
leoylphosphatidylethanolamine; ODN, oligodeoxynucleotide; PBS, phosphate bu¡ered saline; Pyr-PC, 1-hexadecanoyl-2-(1-pyrenedeca-
noyl)-glycero-3-phosphocholine; RBC, red blood cells ; Rho-PE, 1,2-dioleoyl-glycero-3-phosphoethanolamine-N-(lissamine rhodamine L
sulfonyl) ; TX-100, Triton X-100
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drugs [1,2]. Lipofection in vitro involves mixing pre-
formed polycationic lipid vesicles with polyanionic
DNA and incubating the resulting lipid/DNA par-
ticles, sometimes referred to as lipoplexes, with cells
in culture. The e⁄ciency of successful DNA delivery
into the cytoplasm is dependent on the charge ratio
(+/3) of the lipid/DNA particles and their lipid com-
position. The most active lipid/DNA particles usually
contain unsaturated lipids, in particular DOPE [3^5].
Positively charged lipid/DNA particles avidly bind to
cell surfaces and enter cells by endocytosis [6,7]. It is
also apparent that active DNA transfer is dependent
upon the subsequent disruption of the endosome and
concomitant release of all or at least a proportion of
the DNA from intracellular organelles. The molecu-
lar mechanism by which this is induced by lipids
remains poorly characterized and a better under-
standing of the process is necessary for the rational
design of non-viral delivery systems to enhance the
clinical utility of gene drugs.
The synthetic, unsaturated phospholipid DOPE
has been identi¢ed as a neutral lipid, which greatly
enhances the e⁄ciency of lipofection [8,9]. It is typ-
ically combined with equimolar cationic lipid and the
mixture hydrated to form multilamellar liposomes,
which are then reduced to unilamellar vesicles by
sonication or extrusion prior to their being added
to DNA. Unsaturated phosphatidylethanolamine
(PE) is a common class of membrane lipid and ex-
tensive studies have linked it with membrane fusion
events in vitro and in vivo [10]. It is unique amongst
the common mammalian phospholipids because it
prefers to adopt non-bilayer structures in isolation.
When mixed with the appropriate co-lipids PE will
adopt a stable bilayer con¢guration. However, spe-
ci¢c conditions can be applied that induce PE to
promote the formation of non-bilayer structures
such as inverted micelles and membrane stalks,
which have been proposed to act as intermediates
that facilitate fusion [5,10].
Despite the strong link between DOPE and mem-
brane fusion, a number of studies have failed to ¢nd
a correlation between the inherent fusion activity of
lipid/DNA particles in general and their transfection
e⁄ciency. For example, fusion is generally monitored
by lipid mixing assays, but it has been observed that
most cationic lipid vesicles undergo lipid mixing with
anionic membrane targets whether they support
transfection or not [11^14]. Furthermore, some cati-
onic lipid formulations show relatively good activity
in the absence of a neutral lipid [15^17]. In order to
gain a better understanding of the role played by
DOPE in DNA transfer we have conducted a de-
tailed study into the comparative activity of two sim-
ilar lipid/DNA particles, which di¡er only in the
headgroup composition of the neutral lipid. In con-
trast to DOPE, DOPC prefers the bilayer con¢gura-
tion, is not fusogenic and does not promote trans-
fection [3,5,9,18]. The extent to which the two
particles interact with plasma and endosomal mem-
branes was measured employing lipid mixing assays.
Their capacity to transfer plasmid DNA into cells
was determined by measuring the activity of L-galac-
tosidase (L-gal) or luciferase following transfection.
Intracellular delivery of oligonucleotide DNA was
investigated by monitoring tra⁄cking and nuclear
delivery of £uorescent ODN and lipid as well as mea-
suring the e¡ect of an antisense ODN targeting hu-
man epidermal growth factor receptor (EGFR) on
target mRNA levels.
2. Materials and methods
2.1. Materials
DOPE and DOPC were purchased from Northern
Lipids (Vancouver, B.C., Canada). Dr. S. Ansell syn-
thesized DODAC at Inex Pharmaceuticals (Burnaby,
B.C., Canada). 14C-CHE and 3H-CHE were from
Amersham Corp. (Arlington Heights, IL, USA)
while 3H-inulin was from Dupont NEN (Boston,
MA, USA). Rho-PE and NBD-PE were from Avanti
Polar Lipids (Alabaster, AL, USA) and Pyr-PCPC
was from Molecular Probes (Eugene, OR, USA). In-
£uenza virus was obtained from the laboratory of Dr
Jan Wilschut (University of Groningen, The Nether-
lands). Virus particles were grown in and subse-
quently harvested from the allantoic £uid of embry-
onic chicken eggs as described previously [19]. Bio-
Beads (SM2) were obtained from Fluka (Buchs,
Switzerland). A 15-mer, phosphorothioate antisense
ODN against human EGFR with the sequence 5P-
CCGTGGTCATGCTCC-3P [20] and corresponding
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scrambled control sequence 5P-CGCGATTCCGT-
CCGT-3P were synthesized by the Oligonucleotide
Synthesis Laboratory at the University of British Co-
lumbia (Vancouver, B.C., Canada). The plasmids
used, pCMVL-gal and pCMVLuc, were constructed
by Dr. Patrick Tam (Inex Pharmaceuticals Corp.,
Vancouver, B.C., Canada) and contain the reporter
genes L-galactosidase and luciferase respectively,
under the control of the murine CMV immediate
early promoter. The plasmids were puri¢ed using
the alkali lysis method followed by two rounds of
CsCl/ethidium bromide equilibrium centrifugation.
DMEM was from Stem Cell Technologies Inc. (Van-
couver, B.C., Canada) and serum was from Intergen
Company (Purchase, NY, USA). Mouse anti-human
EGFR and phycoerythrin conjugated sheep anti-
mouse IgG antibodies were from Pharmingen (Los
Angeles, CA, USA) and Sigma (Oakville, Ont., Can-
ada) respectively.
2.2. Vesicles
Equimolar quantities of the cationic lipid DODAC
and neutral lipid DOPE or DOPC were mixed in
chloroform and dried under a stream of nitrogen
gas. The thin lipid ¢lm was exposed to high vacuum
for approximately 2 h to remove residual solvent
before hydration with distilled water to form multi-
lamellar vesicles, typically at a concentration of 40
mM total lipid. The vesicles were freeze-thawed ¢ve
times utilizing liquid nitrogen and warm water cycles
and then extruded through 0.1 Wm pore-sized poly-
carbonate ¢lters using an Extruder (Lipex Biomem-
branes, Vancouver, B.C., Canada) to generate large
unilamellar vesicles [21].
2.3. Formation of lipid/DNA particles
Cationic vesicles were mixed with equal volumes of
plasmid DNA or ODN (0.01 mg/ml ¢nal concentra-
tion) in distilled water and incubated at room tem-
perature for 10^20 min before use. The vesicle to
nucleotide ratios are expressed in terms of a +/3
charge ratio calculated by assuming mean molecular
weights for phosphodiester and phosphorothioate
nucleotide sodium salts of 325 and 341 respectively.
One nucleotide base carries one negative charge
while DODAC has one positive charge.
2.4. Transfection of BHK cells
BHK-21 cells were plated the night before in 96-
well plates at 4U104 cells/well in 5% FBS^DMEM.
pCMVL-gal or pCMVLuc plasmid DNA (0.5 Wg/
well, 50 Wl) complexed to various amounts of
DODAC/DOPE or DODAC/DOPC vesicles (+/3
charge ratio range of 0.8 to 2.0) were added to the
cells in 0.2 ml of 5% FBS^DMEM. After 20 h, the
cells were gently rinsed with PBS before being lysed
with 50 Wl PBS containing 0.1% v/v TX-100 and two
freeze-thaw cycles. An aliquot (20 Wl) of the cell ly-
sate was taken for protein determination using a
BCA protein assay. The remaining cell lysate was
assayed for L-galactosidase activity using a photo-
metric method [3] or luciferase activity using a com-
mercial kit (Promega, WI, USA).
2.5. Virosome preparation
Reconstituted in£uenza virus envelopes (viro-
somes) were made following the method of Stegmann
et al. [22]. The viral envelope of in£uenza virus was
solubilized in the detergent octaethylene glycol n-do-
decyl monoether in the presence of 10 mol% Pyr-PC
relative to total viral phospholipid, which was deter-
mined by lipid extraction [23] and phosphate assay
[24]. The viral nucleocapsid was removed by ultra-
centrifugation at 85 000Ug for 30 min at 4‡C. The
supernatant, containing the viral envelope proteins,
lipids and Pyr-PC, was shaken with Bio-Beads SM2
to remove the detergent. Subsequently, the virosome
preparation was centrifuged on a 10^40% (w/v) dis-
continuous sucrose density gradient at 13 000Ug for
90 min and virosomes collected from the interface
between the sucrose layers.
2.6. Virosome fusion with BHK cells
A million BHK cells were suspended in 2 ml of
HBSS containing 0.1% w/v BSA at 37‡C. Pyr-PC
labeled virosomes (0.2 WM ¢nal phospholipid con-
centration) were added to the cells and Pyr-PC ex-
cimer £uorescence monitored employing an Aminco
Bowman Series 2 £uorimeter (SLM Aminco, Ur-
bana, IL, USA) equipped with a magnetic stirrer
and a temperature regulated water jacket. The £uo-
rescence for in¢nite dilution of Pyr-PC was deter-
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mined by the addition of 1 M octyl glucopyranoside
to give a ¢nal concentration of 50 mM. For fusion
measurements in the presence of NH4Cl, an aliquot
of a concentrated stock of NH4Cl was added to the
cell suspension to give a ¢nal concentration of 50 mM
15 min prior to the addition of virosomes and was
present throughout the experiment. The pyrene £uo-
rophore forms £uorescent excimers, consisting of
dimers of one molecule in the ground state and the
other in the excited state [25]. The formation of pyr-
ene excimers is proportional to the membrane den-
sity of pyrene labeled lipids. A decrease in the exci-
mer £uorescence is indicative of fusion with
unlabeled membrane as exogenous lipids dilute the
Pyr-PC. Fusion was calculated as follows:
%fusion  100UFo3F 0o3F3F 0o=Fo3F 0o
31:05Fr3F 0r
where: Fo = initial £uorescence of the cell and viro-
some suspension, FPo = £uorescence (light scattering)
measured in the presence of cells only, F = £uores-
cence at a given time point, Fr = £uorescence of cells
and virosomes after addition of detergent,
FPr = £uorescence (light scattering) of cells in the
presence of detergent, 1.05 = dilution factor to ac-
count for the volume of added detergent.
2.7. Lipid mixing between lipid/DNA particles and
BHK cells in bu¡er
Following the method reported by Wrobels and
Collins [18], 40 nmol of vesicle total lipid complexed
to DNA (+/3 charged ratio = 1) were incubated with
2U105 BHK cells in 1 ml of ice-cold PBS. After 15
min, unbound lipid/DNA particles were removed by
centrifugation of the cells at 4‡C. The cell pellet was
resuspended in 1 ml of ice-cold PBS and centrifuged
a second time. The cells were resuspended in 0.1 ml
of ice-cold PBS and transferred into a cuvette con-
taining 3 ml of PBS at 37‡C. Pyrene £uorescence was
monitored as described above.
2.8. Lipid mixing between lipid/DNA particles and
BHK cells in the presence of serum
Lipid/DNA particles were made in distilled water
using vesicles labeled with 10 mol% Pyr-PC and
2.3 WCi 3H-CHE/Wmol lipid at a charge ratio (+/3)
of 1.0. The particles (3 Wg DNA in 300 Wl) were
added to BHK cells plated the night before at
5U105 cells/well (30 mm diameter) in the presence
of 2 ml 5% FBS^DMEM at 4‡C for 1 h to allow
cell binding to occur. After 1 h the particles were
removed, cells washed with PBS and either assayed
immediately or incubated for a further 3 h at 37‡C in
5% FBS^DMEM. To assay for lipid mixing, the cells
were trypsinized, pelleted and resuspended in PBS.
Pyrene excimer £uorescence was measured as de-
scribed above and normalized to the total amount
of lipid bound as determined by radioactivity. Light
scattering corrections were made for the cells in sus-
pension by comparing the cell concentration, as
measured using a hemocytometer, to a standard
curve constructed using untreated cells.
2.9. Downregulation of EGFR mRNA by antisense
ODN
KB cells were plated the night before at 3.5U105
cells/well (30 mm diameter) in DMEM containing
10% FBS. Lipid/ODN particles (0.5 ml) were pre-
pared as described above and added to the cells in
2 ml of 10% FBS^DMEM at a ¢nal concentration of
400 nM ODN. After 5 h, total RNA was extracted
from the cells using a Qiagen Rneasy kit (Qiagen
Inc., Santa Clarita, CA, USA). The puri¢ed RNA
samples were resolved on a 1% agarose gel contain-
ing 6.7% formaldehyde and transferred to nylon
membranes by capillary elution. The blots were hy-
bridized with EGFR and G3PDH cDNA probes ra-
diolabeled with [K-32P]dCTP by random primer la-
beling using a commercial T7 polymerase kit
(Promega, WI, USA). Probes hybridized to mRNA
transcripts were visualized and quanti¢ed employing
a PhosphorImager (Molecular Dynamics, CA, USA).
2.10. FITC £uorescence measurements in KB cells
KB cells, plated the day before at 3.5U105 cells/
well (30 mm diameter), were exposed to 0.5% Rho-
PE labeled lipid/FITC^ODN particles at a ¢nal con-
centration of 800 nM phosphorothioate ODN in 8%
FBS^DMEM at 4‡C. Note that £uorescence micros-
copy indicated that whilst at 4‡C, Rho-PE £uores-
cence remained punctate at the cell surface, which
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supports the assumption that little if any lipid mixing
or endocytosis occurs at this temperature. In con-
trast, when the cells were raised to 37‡C di¡use
Rho-PE £uorescence was observed associated with
the plasma membrane and punctate £uorescence
with endocytic vesicles. After 1 h, unbound lipid/
DNA particles were removed, fresh media added
and the cells incubated at 37‡C. At various times
the cells were lifted from the plate with 2 mM
EDTA in PBS, pelleted and then resuspended in
PBS. FITC £uorescence of the cell suspension was
measured at excitation and emission wavelengths of
482 nm and 520 nm respectively. Total FITC £uo-
rescence was obtained by diluting the cell suspension
three times with PBS in the presence of 0.5% v/v TX-
100. Light scattering corrections for the cell suspen-
sions were made as described above.
2.11. Preparation of red blood cell ghost membranes
An aliquot (2 ml) of packed, freshly collected hu-
man blood was lysed by rapid dilution in 300 ml of
ice-cold lysis bu¡er (5 mM EDTA, 5 mM HEPES,
pH 7.4). The lysed red blood cells (RBC) were then
pelleted by centrifugation at 27 000Ug for 40 min at
4‡C. The pellet was resuspended in lysis bu¡er and
pelleted again three times or until the RBC mem-
brane preparation was white. The resulting RBC
ghosts were resealed with HBS containing 5 mM
MgCl2 and incubated at 37‡C for 1 h. They were
then isolated again by centrifugation at 27 000Ug,
suspended in HBS and stored in small aliquots at
320‡C until required.
2.12. Lipid mixing with RBC ghosts
A £uorescent assay based on resonance energy
transfer between NBD-PE (the energy donor) and
Rho-PE (the energy acceptor) was used to measure
the extent of lipid mixing [26]. Lipid/DNA particles,
made with vesicles containing 1 mol% Rho-PE and
1 mol% NBD-PE, were added to RBC ghosts in
10 mM HEPES, pH 7.4 at 25‡C. Fluorescence
from NBD-PE was monitored at excitation and
emission wavelengths of 460 nm and 530 nm respec-
tively, using a £uorimeter. Total £uorescence was
determined following the addition of TX-100 (1%
v/v ¢nal concentration) which represents maximum
dilution of the probes and therefore maximum
NBD-PE £uorescence.
2.13. Hemolysis measurements
Human blood, freshly collected in EDTA-vacu-
tainer tubes from healthy volunteers, was washed
three times with cold HBS and pelleted by centrifu-
gation at 2000 rpm for 10 min. The pellet of packed
cells was resuspended in 10 volumes of HBS, an ali-
quot was subjected to chloroform/methanol extrac-
tion [23] and the chloroform phase analyzed for
phosphorus content [24] to determine the phospho-
lipid concentration (approximately 0.25 WM cell
phospholipid) and kept on ice until use. Aliquots
of fresh RBC, pre-washed with HBS, were added
to cationic lipid vesicles or lipid/DNA particles
(+/3 charge ratio = 1) in HBS or HBS containing
5% FBS and incubated for 30 min at 37‡C. Unlysed
RBC were pelleted by centrifugation at 2000 rpm for
10 min and the hemoglobin content in the superna-
tant measured at an absorbance of 405 nm using a
Biolumin960 plate reader (Molecular Dynamics,
Sunnyvale, CA, USA). Total hemolysis was meas-
ured by lysing an aliquot of cells in excess distilled
water.
2.14. Vesicle binding to RBC
Lipid/DNA particles were prepared containing
trace amounts of 14C-CHE. RBC were exposed to
the particles for 5 min at 4‡C in HBS spiked with
0.13 WCi/ml 3H-inulin. Unlysed cells were pelleted at
2000 rpm using a centrifuge pre-cooled to 4‡C and
an aliquot of the supernatant was removed to deter-
mine the degree of hemolysis. The amount of vesicles
bound to cells was determined from the level of
14C-CHE associated with the RBC pellet. 3H-inulin
was used to calculate the extracellular volume so that
the pellet radioactivity could be corrected for un-
bound vesicles. Controls conducted in the absence
of RBC indicated that vesicles did not pellet under
the centrifugation conditions employed.
2.15. Miscellaneous analytical procedures
Protein concentrations were measured using a
standard BCA protein assay. Vesicle sizes were de-
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termined by quasi-elastic light scattering (QELS) us-
ing a Nicomp 370 submicron particle sizer (Nicomp
Instruments, Goleta, CA, USA) operating at 632.8
nm and 5 mW. Radioactivity was measured by liquid
scintillation counting using a Beckman LS3801 in-
strument. Fluorescence micrographs were prepared
employing a Nikon Diaphot 300 epi£uorescence mi-
croscope, equipped with a 450^490 nm wavelength
excitation ¢lter, 510 nm dichromatic mirror and a
520 nm barrier ¢lter.
3. Results
3.1. Lipid/DNA particles and gene transfer
The cationic lipid employed in these studies (DO-
DAC) is a dimethylammonium chloride salt with two
18-carbon monounsaturated (di-18:1) alkyl chains
covalently linked directly to the nitrogen (Fig. 1).
In combination with DOPE, the di-18:1 derivative
exhibits the highest level of gene transfer activity
when compared to other lipids in the series in which
the alkyl chains are varied [5]. The characteristics of
DODAC are similar to those observed for other uni-
valent cationic lipids capable of supporting lipid-
mediated gene transfer [27]. When equimolar with
DOPE it will stabilize the bilayer con¢guration as
determined by 31P-NMR (data not shown). And as
a component of small unilamellar lipid vesicles it will
charge neutralize DNA causing the nucleic acid to
condense into lipid/DNA particles in which the nu-
cleic acid is no longer accessible to ethidium bromide
or other intercalating dyes [5]. Compaction of plas-
mid DNA occurs as a result of charge neutralization
by polycations and when induced by cationic lipid
vesicles the process appears to be independent of
the nature of the lipids employed. Consequently, lip-
id/DNA particles formed using DODAC/DOPC or
DODAC/DOPE vesicles appear to be indistinguish-
able [5]. Transfection, however, is very much lipid
dependent and cationic lipid/DNA particles contain-
ing DOPE show greatly enhanced activity compared
to the same particles prepared with DOPC (Fig. 2).
3.2. Lipid mixing and transfection activity
In order to compare the lipid mixing activities of
the low transfection (DOPC-containing) and high
transfection (DOPE-containing) lipid/DNA particles
we employed a Pyr-PC assay that has been used ex-
tensively to characterize the fusion of reconstituted
viral particles (virosomes) with cells growing in cul-
ture [22,28]. In order to validate this assay we re-
peated the work described by Stegmann et al. [22]
employing virosomes that contain the in£uenza fu-
sion protein hemagglutinin (HA). Virosomes con-
taining 10 mol% Pyr-PC were prepared as outlined
in Section 2, and a time course of their fusion with
BHK cells at 37‡C is shown in Fig. 3 (circles). Two
features indicate that fusion between virosomes and
endosomal membranes occurs as described previ-
ously [22,28]. First, Pyr-PC dilution and concomitant
decrease in excimer £uorescence occur only after a
10^20 min lag period. This re£ects the time required
for endocytosis to take place followed by acidi¢ca-
tion of the endosomal compartment. At pH6 5.5
HA undergoes a conformational change that acti-
vates the fusion process. Second, the presence of
Fig. 2. Transfection of BHK cells mediated by DODAC/DOPE
and DODAC/DOPC vesicles. BHK cells, plated the night be-
fore at 4U104 cells/0.32 cm2, were exposed to 0.5 Wg of
pCMVL-gal or pCMVLuc plasmid complexed to various
amounts of DODAC/DOPE (hatched bars) or DODAC/DOPC
(open bars) vesicles in the presence of 5% FBS^DMEM. After
20 h, L-galactosidase or luciferase protein expression was as-
sayed as outlined in Section 2. The data plotted are at the max-
imum transfection e⁄ciency observed over a charge ratio range
of 0.8 to 2.0, which for L-galactosidase and luciferase were at
+/3 charge ratios of 1.3 and 1.2, respectively. The data have
been normalized to the transfection e⁄ciency obtained with
DODAC:PE and represent an average of three samples þ one
S.D.
Fig. 1. Structure of DODAC.
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50 mM NH4Cl inhibits the lipid mixing because it
prevents acidi¢cation of the endosome and therefore
activation of the viral fusion protein.
In contrast to the controlled, pH-dependent fusion
of the virosomes, lipid/DNA particles under the same
conditions undergo extensive lipid mixing immedi-
ately upon contact with the plasma membrane at
37‡C in PBS (Fig. 3, squares) or PBS containing
0.1% w/v BSA (data not shown). Moreover, despite
the fact that DOPE-containing particles support
transfection to a greater extent than particles con-
taining DOPC there was no di¡erence in their ability
to support lipid mixing with the plasma and endo-
somal membranes of BHK cells. Fluorescence mi-
croscopy also revealed the presence of £uorescent
plasma membranes after BHK cells were incubated
with Rho-PE labeled lipid/DNA particles, supporting
the observation that signi¢cant lipid mixing occurs
prior to and during the uptake process. Furthermore,
50 mM NH4Cl had no e¡ect on the £uorescence
pro¢les shown in Fig. 3 for lipid/DNA particles
(data not shown) indicating that lipid mixing was
not pH dependent, as it is for the virosome, but
occurs spontaneously following lipid/DNA binding
to the cell surface.
3.3. The e¡ect of serum on lipid mixing
The mixing data described above were obtained in
the presence of bu¡er or low concentrations of BSA
according to the virosome method being followed
and not the presence of 5^10% serum typically used
for transfection. However, it has been noted previ-
ously that in vitro serum generally inhibits the trans-
fection activity of lipid/DNA particles [29]. Transfec-
tion by DODAC/DOPE vesicles is reduced but not
eliminated by serum and the di¡erence in activity
between DOPE- and DOPC-containing lipid/DNA
particles remains similar to that shown in Fig. 2.
To compare lipid mixing for the two DNA delivery
systems in the presence of serum, lipid vesicles were
labeled with 10% Pyr-PC and 3H-CHE. Lipid/DNA
particles were prepared at a +/3 charge ratio of 1.0
(previously optimized to give maximum transfection
for the plasmid) and added to plated BHK cells in
the presence of 5% FBS^DMEM at 4‡C. After 1 h
unbound material was removed and replaced with
fresh media then cells were incubated for a further
3 h at 37‡C. Pyrene £uorescence at 1 h (bound) was
then compared to £uorescence at 4 h (bound and
endocytosed) after normalizing to the total amount
of 3H-lipid associated with the cells. A signi¢cant
drop (P6 0.001) in excimer £uorescence occurs for
both DOPC- and DOPE-containing particles during
the 3 h incubation at 37‡C (Fig. 4, hatched bars),
indicating extensive lipid mixing has taken place. In
this series of experiments a 60 þ 30% decrease in £uo-
rescence was observed for DOPE-containing particles
compared to 30+30% for those containing DOPC,
however the di¡erence is not statistically signi¢cant
(n = 7). The amount of lipid bound to the cells for
both DOPC- and DOPE-containing particles was
similar, approximately 30 pmol lipid per 1 million
cells. These data support the observations made
above and indicate that lipid mixing alone does not
explain the large di¡erences in transfection activity
between the two delivery systems.
Fig. 3. Lipid mixing of virosomes and lipid/DNA particles with
BHK cells measured by Pyr-PC. Virosomes were incubated
with BHK cells in HBSS-BSA bu¡er in the absence (b) or pres-
ence (a) of 50 mM NH4Cl at 37‡C as previously described
[22]. In the latter case, the cells were pre-incubated with 50 mM
NH4Cl for 15 min prior to the addition of virosomes. Alterna-
tively, following the method of Wrobel and Collins [18], DO-
DAC/DOPE (F) or DODAC/DOPC (E) vesicles complexed to
DNA (+/3 charge ratio = 1) were pre-bound to BHK cells in
1 ml of PBS at 4‡C. After 15 min, unbound vesicles were re-
moved by pelleting the cells. The cell pellet was resuspended in
0.1 ml of ice-cold PBS prior to being added to a cuvette con-
taining 3 ml of PBS at 37‡C (time zero). Pyrene excimer £uo-
rescence was monitored with continuous stirring at excitation
and emission wavelengths of 345 and 480 nm, respectively. Fi-
nal £uorescence was obtained by addition of OGP (50 mM ¢-
nal) and % fusion calculated as outlined in Section 2.
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3.4. Intracellular delivery of antisense
oligodeoxynucleotides
Lipids used for gene transfer can also be applied to
antisense ODN [4]. Successful intracellular delivery
of nuclease resistant phosphorothioate ODN can be
observed not only by monitoring the downregulation
of target mRNA and protein but also by the appear-
ance of £uorescent nuclei when FITC-tagged ODN
are incorporated into the lipid/ODN particles [30,31].
When FITC labeled phosphorothioate ODN are in-
jected directly into the cytoplasm they rapidly di¡use
into the nucleus [32], consequently, they make excel-
lent markers for intracellular delivery and endosomal
release.
For the studies reported here we employed a 15-
mer phosphorothioate ODN complementary to the
human EGFR stop codon region [20]. Following de-
livery by DODAC/DOPE vesicles into human KB
cells the antisense reduced levels of EGFR mRNA
by as much as 80% after 24 h compared to glycer-
aldehyde 3-phosphate dehydrogenase (G3PDH)
mRNA, whereas a scrambled control and lipid alone
had no e¡ect (Fig. 5A). Replacing DOPE with
DOPC eliminated the antisense activity (Fig. 5B),
even though the extent of ODN uptake was the
same for both lipid/ODN particles, approximately
0.3 ng ODN/mg cell protein. The di¡erent activity
of the two phospholipids is also clearly illustrated
in Fig. 6, where the intracellular fate of lipid/ODN
particles labeled with Rho-PE and FITC^ODN is
shown. Approximately 4 h after uptake the nuclei
of KB cells treated with lipid/ODN particles contain-
ing DOPE appear green due to the accumulation of
FITC^ODN. The orange £uorescence of Rho-PE is
clearly visible in the perinuclear region, indicating
Fig. 5. Antisense activity mediated by lipid/ODN complexes in
KB cells. (A) DODAC/DOPE vesicles were mixed with the ac-
tive EGFR (b) or scrambled (a) antisense ODN in distilled
water and added to KB cells at a concentration of 400 nM in
8% FBS^DMEM. Control cells were exposed to an equivalent
amount of distilled water (R). At various times, total RNA
was isolated from the cells. A Northern blot of the extracted
RNA was probed for EGFR and G3PDH mRNA and quanti-
tated using a phosphoimager. (B) DODAC/DOPE or DODAC/
DOPC vesicles were mixed with the active EGFR (hatched
bars) or scrambled (open bars) ODN and added to KB cells as
outlined above. After 5 h, the cells were assayed for EGFR
mRNA content. The data represent an average of three samples
þ one S.D.
Fig. 4. Lipid mixing of lipid/DNA complexes with BHK cells in
the presence of serum. Lipid/DNA complexes were made with
DODAC/DOPE or DODAC/DOPC vesicles labeled with 10
mol% Pyr-PC and 3H-CHE and added to plated sub-con£uent
BHK cells in the presence of 5% FBS^DMEM at 4‡C. After
1 h, unbound complexes were removed, cells washed with PBS
and either assayed (open bars) or incubated for a further 3 h at
37‡C (hatched bars) in 5% FBS^DMEM. To assay for lipid
mixing, the cells were detached from the plate with 2 mM
EDTA, pelleted and resuspended in PBS. Pyrene excimer £uo-
rescence was measured as outlined in Section 2 and the results
expressed as pyrene excimer £uorescence normalized to the
amount of lipid bound as determined by 3H-CHE. The data
represent the average of seven samples þ one S.D.
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that the lipid remains associated with intracellular
membranes and does not cross the nuclear envelope
(Fig. 6A). Marcusson et al. [31] have made similar
observations during the lipid-based delivery of anti-
sense ODN targeting protein kinase C-alpha, these
authors also demonstrated that target mRNA did
not start to decline until nuclear £uorescence could
be observed.
In contrast, lipid/ODN particles containing DOPC
remain trapped within the endosome/lysosome path-
way (Fig. 6B), where the FITC £uorescence is
quenched by a combination of the low pH and close
proximity to Rho-PE [33]. Confocal microscopy also
con¢rmed that both types of lipid/ODN particles
were endocytosed (data not shown). The increase in
FITC^ODN £uorescence as it is released from
quenching conditions and accumulates in the nucleus
can also be used to quantitatively monitor intracel-
lular release of ODN, as demonstrated in Fig. 7.
Lipid/ODN particles made with FITC^ODN were
pre-bound to KB cells at 4‡C for 1 h, then unbound
particles were removed and the cells incubated with
fresh media (time zero). At various times, cellular
FITC £uorescence was measured as outlined in Sec-
tion 2. The data show that as DOPE-containing lip-
id/ODN particles are endocytosed and processed fur-
ther, FITC £uorescence increases rapidly during the
¢rst 4 h, which correlates with the appearance of
£uorescent nuclei. On the other hand, the £uores-
cence measured from DOPC-containing particles
gradually decreases, which is consistent with the in-
creased quenching expected as the endosome com-
partment acidi¢es.
3.5. Lipid mixing and membrane perturbation
We have demonstrated that lipid/DNA particles
containing equimolar DODAC and the phospholip-
Fig. 6. Fluorescent microscopy of KB cells exposed to Rho-PE labeled lipid/FITC^ODN particles. DODAC/DOPE (panels A and C)
or DODAC/DOPC (panels B and D) vesicles labeled with 0.5 mol% Rho-PE were complexed to FITC^ODN and added to KB cells
at a concentration of 410 nM ODN in 8% FBS^DMEM and incubated at 37‡C for 4 h.
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ids DOPC or DOPE undergo lipid mixing with cell
membranes to a similar extent, yet only DOPE sup-
ports extensive DNA (plasmid or phosphorothioate
ODN) transfer into the cytoplasm or nucleus. To
investigate this further we examined the e¡ects of
lipid mixing on the integrity of the red blood cell
(RBC) plasma membrane, which was used as a mod-
el representative of a typical biological membrane. In
the ¢rst series of experiments we employed £uores-
cence energy transfer to con¢rm that lipid/DNA
(plasmid) particles (+/3 charge ratio 1.0) containing
Rho-PE and NBD-PE mix rapidly with RBC mem-
branes at 37‡C, behavior similar to that described
above for BHK cells. Red blood cell ghosts were
used to avoid any interference with the assay from
hemoglobin. Extensive lipid mixing was observed
after only 10 min for both DOPE- and DOPC-con-
taining particles, 98 þ 6% and 58 þ 5% of maximum
probe dilution respectively.
In order to determine what e¡ect lipid mixing with
the plasma membrane has on membrane integrity,
lipid vesicles and lipid/DNA particles were incubated
with intact RBC and hemolysis measured as an in-
dicator of membrane perturbation. At ratios of
vesicle lipid to RBC membrane lipid of approxi-
mately 0.5:1 the data show that both vesicles alone
and lipid/DNA (plasmid) particles containing DOPE
are much more hemolytic than those containing
DOPC (Fig. 8). Binding studies demonstrated that
the total amount of cell-associated lipid is the same
for both DOPE- and DOPC-containing systems.
Consequently, taken together with the lipid mixing
results, these data suggest that the RBC plasma
membrane is destabilized to a greater extent by an
in£ux of DOPE than it is by an equivalent in£ux of
DOPC.
4. Discussion
The focus of this work was to measure the mem-
brane interactions of two closely related cationic lip-
id vesicles that di¡er greatly in their capacity to
transfer DNA into cells in vitro. Since the ¢rst report
by Felgner et al. [8] demonstrating that cationic lipo-
somes containing DOPE can e⁄ciently deliver func-
tional plasmid into mammalian cells, there have been
many attempts to correlate the fusion activity of lip-
id/DNA particles with their ability to transfect. This
is because it is widely accepted that a non-viral gene
Fig. 8. Hemolysis of RBC by lipid vesicles and lipid/DNA
particles. Fresh RBC (25 nmol phospholipid) were added to
10 nmol DODAC/DOPE (hatched bars) or DODAC/DOPC
(open bars) vesicles and hemolysis measured after a 30 min in-
cubation at 37‡C as outlined in Section 2. Vesicles were also
complexed to DNA (charge ratio = 1) prior to adding to RBC.
The data represent an average of three samples þ one S.D.
Fig. 7. Quantitation of endosomal release of FITC^ODN in
KB cells after exposure to lipid/FITC^ODN particles. DODAC/
DOPE (F) or DODAC/DOPC (E) vesicles labeled with 0.5
mol% Rho-PE were complexed to FITC^ODN and added to
KB cells at a concentration of 820 nM ODN in 8% FBS^
DMEM at 4‡C. After 1 h, unbound complexes were removed,
fresh media added and the cells incubated at 37‡C (time zero).
At various times, cellular FITC £uorescence was determined by
detaching the cells from the plate with 2 mM EDTA. The cells
were pelleted, resuspended in PBS and FITC £uorescence meas-
ured using an SLM Aminco £uorimeter at excitation and emis-
sion wavelengths of 482 nm and 520 nm, respectively. Total
FITC £uorescence was determined after addition of 0.5% TX-
100. Corrections were made for light scattering as outlined in
Section 2. The data represent an average of three samples þ one
S.D.
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delivery system, that can mimic the DNA delivery
mechanisms of viruses by fusing with plasma or en-
dosomal membranes to release a nucleic acid payload
directly into the cytoplasm, will speed the clinical
development of gene therapy [1,2]. Given the well-
known relationship between unsaturated phosphati-
dylethanolamine, non-bilayer lipid structures and
membrane fusion [10] it is reasonable to speculate
that DOPE is responsible for enabling lipid/DNA
particles to fuse with either the plasma membrane
or endosomal membrane after phagocytosis [9].
However, despite many attempts to con¢rm this
hypothesis a correlation between lipid mixing (com-
monly assumed to re£ect fusion processes) of non-
viral, lipid-based delivery systems and transfection
has not been clearly established [11^14]. Here we
demonstrate that lipid/DNA particles containing
DOPC exhibit levels of transfection that are 10- to
100-fold less than can be achieved with DOPE-con-
taining particles (Fig. 2), yet both systems readily
undergo lipid mixing with cell membranes (Figs. 3
and 4). Similar behavior is seen for antisense deliv-
ered by cationic lipid vesicles. In the presence of
DOPE a sequence speci¢c antisense e¡ect on
mRNA and protein levels can be measured, indicat-
ing that ODN has accessed the cell cytoplasm and
nucleus. No such e¡ects, however, are observed when
antisense is delivered using vesicles in which DOPC
has been substituted for DOPE (Fig. 5). Fluorescence
microscopy shows that in the presence of DOPC the
ODN cannot escape from the endosomal pathway
(Fig. 6), whereas in the presence of DOPE, ODN
accumulates in nuclei and appears to separate from
lipid, which remains associated with intracellular or-
ganelles.
From these data we conclude that fusion, hemi-
fusion or close apposition resulting in extensive lipid
mixing between plasma or endosomal membranes
and bound cationic lipid/DNA particles, is not nec-
essarily su⁄cient to induce the release of DNA into
the cytoplasm. We propose that the nature of the
exogenous lipid being inserted into the biological
membrane is more relevant than the lipid mixing
event itself. It is known, for example, that RBC
can tolerate larger amounts of exogenous phosphati-
dylcholine in the outer monolayer of the plasma
membrane if the fatty acid composition re£ects that
of the endogenous lipid [34], an incompatible fatty
acid composition results in hemolysis. One explana-
tion for the di¡erent DNA delivery activities of DO-
DAC/DOPE and DODAC/DOPC we observe, de-
spite similar binding, cell uptake and lipid mixing
behavior, is that the plasma and endosomal mem-
branes are more tolerant of exogenous DOPC than
DOPE. The di¡erential hemolysis data presented in
Fig. 8 support this hypothesis. The molecular shape
and non-bilayer structural preferences of DOPE
likely destabilize the membrane resulting in lysis
through pore formation [35] or other types of pertur-
bation [5]. Moreover, the degree of destabilization
induced by excess DOPE, but not DOPC, may also
be expected to induce transbilayer £ip-£op of anionic
membrane lipids capable of displacing cationic lipid
from the DNA thus enhancing the release of nucleic
acid into the cytoplasm [7].
Both types of lipid/DNA particles employed here
undergo lipid mixing with the plasma membrane of
BHK cells without any evidence of a lag period and
independent of endosomal acidi¢cation (Fig. 2). Sim-
ilar behavior has recently been described for 1,2-dio-
leoyl-3-(trimethylammonium) propane (DOTAP),
another cationic lipid commonly used for transfec-
tion in combination with DOPE [14]. These data
suggest that lipid mixing is initiated by close apposi-
tion between lipid/DNA particles and the cell sur-
face. In contrast vesicles containing reconstituted
HA proteins require an acidic environment for fusion
to proceed (Fig. 2). It is interesting to note that we
(data not shown) and others have observed that se-
rum tends to inhibit lipid mixing but does not sig-
ni¢cantly a¡ect the binding of lipid/DNA particles to
cells [14,29]. The exchange of lipids between lipid/
DNA particles coated with serum proteins and cell
membranes may be restricted by the steric and hy-
drophilic barrier presented by the bound protein.
Therefore transfection in the presence of serum
may require at least partial enzymatic digestion of
bound material whilst lipid/DNA particles are in en-
dosome/lysosome compartments.
Phosphatidylethanolamine is not the only lipid ca-
pable of perturbing membrane structure when
present in excess. However, membrane disruption is
only part of the role played by the neutral lipid com-
ponent of cationic lipid/DNA particles. It must also
form bilayer vesicles in combination with a cationic
lipid and subsequently form a protective barrier
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around the nucleic acid to prevent nuclease degrada-
tion by serum nucleases prior to cell uptake. In some
instances multivalent cationic lipids alone have been
demonstrated to successfully deliver DNA into cells
[17] and cholesterol can be substituted for DOPE
with some monovalent cationic lipids [36]. From
the studies presented here we conclude that measur-
ing lipid mixing phenomena alone is not su⁄cient to
predict the transfection potency of lipid-based non-
viral delivery systems. More important is the ability
of the lipids undergoing mixing, either alone or in
combination with endogenous lipids, to cause su⁄-
cient perturbation to enable the nucleic acid to gain
access to the cytoplasm.
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